'Candesartan' presentation slideshows

Journal Club

846 views • 41 slides

Drugs for CCF

Drugs for CCF. Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant fluid retention. It is a leading cause of mortality and morbidity. . Drugs for CCF.

1.52k views • 34 slides

Renin-Angiotensin System Drugs

Renin-Angiotensin System Drugs. Igor Spigelman, Ph.D. Division of Oral Biology & Medicine, UCLA School of Dentistry, CA. Rm. 63-078 CHS. Email: igor@ucla.edu. RENIN-ANGIOTENSIN SYSTEM.

668 views • 19 slides

Candesartan in Heart Failure

CHARM Trial. Candesartan in Heart Failure. Presented at European Society of Cardiology 2003. CHARM Trial. 7,601 patients with heart failure 3 Individual component randomized trials with the ARB candesartan (4 or 8 mg/day, titrated to target dose of 32 mg) or placebo . CHARM Preserved

910 views • 8 slides

Purpose

CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved. Purpose

188 views • 8 slides

Purpose

CHARM Added: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Added. Purpose

198 views • 8 slides

Purpose

CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative. Purpose

126 views • 7 slides

Candesartan Industry Analysis, Market Production 2015 | Prof Research Reports

Get Full Report at: http://www.profresearchreports.com/global-and-chinese-candesartan-cas-139481-59-7-industry-2015-research-report-market Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Candesartan industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.

226 views • 6 slides

Supplementary Figure 4 . Co-administration vs. single candesartan

Supplementary Figure 4 . Co-administration vs. single candesartan

69 views • 1 slides